Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: experience from China

Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: experience from China

Background: Sulfonylurea therapy can improve glycemic control and ameliorate neurodevelopmental outcomes in patients suffering from neonatal diabetes mellitus (NDM) with KCNJ11 or ABCC8 mutations. As genetic testing results are often delayed, it remains controversial whether sulfonylurea treatment s...

Full description

Bibliographic Details
Main Authors: Li, Xiuzhen, Xu, Aijing, Sheng, Huiying, Ting, Tzer Hwu, Mao, Xiaojian, Huang, Xinjiang, Jiang, Minyan, Cheng, Jing, Liu, Li
Format: Article
Language:English
Published: John Wiley and Sons 2018
Online Access:http://psasir.upm.edu.my/id/eprint/72357/1/Early%20transition%20from%20insulin%20to%20sulfonylureas%20in%20neonatal%20diabetes%20and%20follow%E2%80%90up.pdf

Internet

http://psasir.upm.edu.my/id/eprint/72357/1/Early%20transition%20from%20insulin%20to%20sulfonylureas%20in%20neonatal%20diabetes%20and%20follow%E2%80%90up.pdf

Similar Items